ALZAMEND NEURO INC (ALZN)
US02262M4078 - Common Stock
ALZN Stock Earnings: Alzamend Neuro Misses EPS for Q3 2024
ALZN stock results show that Alzamend Neuro missed analyst estimates for earnings per share the third quarter of 2024.
ALZN Stock Earnings: Alzamend Neuro Misses EPS for Q3 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Alzamend Neuro (NASDAQ:ALZN) just reported results for the third quarter of 202...
ALZN Stock Earnings: Alzamend Neuro Beats EPS for Q1 2024
ALZN stock results show that Alzamend Neuro beat analyst estimates for earnings per share the first quarter of 2024.
ALZN Stock Earnings: Alzamend Neuro Beats EPS for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Alzamend Neuro (NASDAQ:ALZN) just reported results for the first quarter of 202...
ALZN Stock Earnings: Alzamend Neuro Reported Results for Q2 2024
Alzamend Neuro just reported results for the second quarter of 2024.
ALZN Stock Earnings: Alzamend Neuro Reported Results for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Alzamend Neuro (NASDAQ:ALZN) just reported results for the second quarter of 20...
Alzamend stock tumbles 18% in wake of clinical study update (NASDAQ:ALZN)
Alzamend (ALZN) stock dropped 18% Tuesday, the day after the company issued an update on a clinical trial for its drug AL001. Read more here.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start Tuesday trading with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning!
Alzamend Neuro Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
